MedTrace Logo

Motion for Recovery: The Impact of Gyrokinesis on Childhood Cancer-Related Fatigue.

NCT07137091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-03-03

No results posted yet for this study

Summary

CRF influences engagement in everyday activities, mood, sleep, social relations, school attendance, academic achievement, and quality of life . It was significantly associated with low health-related quality of life in pediatric cancer patients including leukemia . Since attention to managing cRF has been drawn, only a few non-pharmacological strategies were tested for their effectiveness in reducing cRF among children. Physical activity (Pa) has been proven to be the most effective strategy . Yet adherence to Pa remains problematic.

Conditions

Interventions

OTHER

Gyrokinesis exercise

1. Warm-Up: * Begin with gentle seated movements to prepare the body. * Focus on awakening the spine with small circles and undulating motions, coordinating with deep breathing. 2. Seated Exercises: * Perform a series of exercises on a stool or chair. * Emphasize spinal articulation, pelvic tilts, and side bends while maintaining rhythmic breathing. 3. Floor Work: * Transition to mat-based exercises focusing on core strength and flexibility. * Incorporate movements like leg lifts, spirals, and arching motions to engage different muscle groups. 4. Standing Series: * Conclude with standing exercises to enhance balance and full-body integration. * Use spiral movements and weight shifts to energize the body and improve posture.

Sponsors & Collaborators

  • MTI University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-02-01
Completion
2026-02-05

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07137091 on ClinicalTrials.gov